Current role
Daniel Tardiff, PhD
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Daniel Tardiff, PhD
Camp4 Therapeutics Corp reported in an 8-K filed September 10, 2025 that Daniel Tardiff, PhD was appointed Chief Scientific Officer, effective October 1, 2025.
“On September 10, 2025, the Company issued a press release announcing the Private Placement, the appointment of Douglas Williams, PhD as Chair of the Board, and effective October 1, 2025, the elevation of Daniel Tardiff, PhD to the role of Chief Scientific Officer of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Camp4 Therapeutics Corp (CAMP)
SEC 8-K
Current2025-10-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Camp4 Therapeutics Corp
Other people whose current roles at this company are on record from its filings.
- Josh Mandel-Brehm CEO, Board Member
- Doug Williams Chairman
- Kelly Gold CFO
- Amir Nashat Board Member
- Andrew J. Schwab Board Member
- Douglas Williams Board Member
- Douglas Williams, PhD Board Member
- Michael MacLean Board Member
- Murray Stewart Board Member
- Murray Stewart, DM FRCP Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.